Hybrid heart failure care with home monitoring
Official title: Evalutation of a Hybrid Care Pathway With Remote MONitoring for Heart Failure
Run by St. Antonius Hospital · NCT07680634 · Data updated 2026-11-12
This study tests whether a hybrid care pathway with remote monitoring helps adults with heart failure compared to usual care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 6000 (estimated) |
| Sponsor | St. Antonius Hospital Academic / other |
| Locations | 7 sites (Amsterdam, Utrecht and 6 other locations) |
| Status | Recruiting |
| Started | May 1, 2023 |
| Main results expected | December 30, 2030 |
| Study ends | June 2031 |
| Registry record updated | July 2, 2026 |
| Trial ID | NCT07680634 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with a diagnosis of heart failure who can use digital tools and communicate in Dutch, treated at one of the seven participating hospitals.
✕Probably not a fit
Patients who are unwilling or unable to participate in home telemonitoring or who have end-stage or terminal conditions may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a real-world, multicenter observational cohort study conducted in the Netherlands. It compares patients using home telemonitoring as part of a hybrid care pathway to patients receiving standard care without telemonitoring, across seven hospitals. The program collects daily home measurements and symptoms to trigger early interventions by a Medical Service Center, aiming to improve management in routine clinical practice. The study includes retrospective and prospective components to assess outcomes in typical care settings. Eligible participants are adults with heart failure who can use digital tools and speak Dutch, while those with end-stage disease or unwillingness to participate in remote monitoring are excluded.
Why it matters
Potential benefit: If successful, this approach could improve symptom control and reduce hospitalizations for heart failure patients.
How similar studies have gone: Previous real-world studies of telemonitoring in heart failure have shown mixed but promising signals for improved management and outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (at least 18 years or older) * Diagnosed with heart failure according the prevailling ESC guideline * Treatment at the outpatient clinic at one of the seven participating hospitals * Sufficient digital literacy and adequate Dutch language proficiency by the patient or throught the informal caregiver. Exclusion Criteria: * Inability or unwillingness to participate in home telemonitoring * Patients with end-stage heart failure or other terminal conditions
Where it's running
-
Olvg
Amsterdam, Utrecht, Netherlands Recruiting -
Catharina Hospital
Eindhoven, Utrecht, Netherlands Recruiting -
Medisch Spectrum Twente
Enschede, Utrecht, Netherlands Recruiting -
Martini Hospital
Groningen, Utrecht, Netherlands Recruiting -
St. Antonius Hospital
Nieuwegein, Utrecht, Netherlands Recruiting -
Canisius-Wilhelmina Hospital
Nijmegen, Utrecht, Netherlands Recruiting
Show 1 more location
-
Maasstad Hospital
Rotterdam, Utrecht, Netherlands Recruiting
Study contacts
- Principal investigator: Gerardus PJ van Hout, MD, PhD — St. Antonius Hospital
- Study coordinator: Bart TG Köhlen, MD, MSc
- Email: b.kohlen@antoniusziekenhuis.nl
- Phone: +31883201108
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.